Ellen Philipp

Ellen Philipp has extensive experience in the pharmaceutical industry, currently serving as a Key-Account-Manager at argenx since July 2022, focusing on the launch of Vyvgart. Prior to this role, Ellen Philipp worked at Biogen for over 22 years, holding various positions including District Manager, where responsibilities included team leadership, training, and strategic direction for Alzheimer awareness, as well as Senior Account Manager and Key-Account-Manager with a focus on the launch of Tysabri. Earlier experience includes a role as Area Business Manager at Smith Kline Beecham Pharma, where Ellen Philipp launched Requip, and as a Geprüfte Pharmareferentin at both Essex Pharma GmbH and GSK. Ellen Philipp holds a degree as a Geprüfte Pharmareferentin from IHK.